These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

655 related items for PubMed ID: 20839927

  • 1. New β-lactam antibiotics and β-lactamase inhibitors.
    Bush K, Macielag MJ.
    Expert Opin Ther Pat; 2010 Oct; 20(10):1277-93. PubMed ID: 20839927
    [Abstract] [Full Text] [Related]

  • 2. The new beta-lactamases.
    Jacoby GA, Munoz-Price LS.
    N Engl J Med; 2005 Jan 27; 352(4):380-91. PubMed ID: 15673804
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Bacterial resistance mechanisms to beta-lactam antibiotics: assessment of management strategies.
    Dudley M.
    Pharmacotherapy; 1995 Jan 27; 15(1 Pt 2):9S-14S. PubMed ID: 7753692
    [Abstract] [Full Text] [Related]

  • 5. The emergence and implications of metallo-beta-lactamases in Gram-negative bacteria.
    Walsh TR.
    Clin Microbiol Infect; 2005 Nov 27; 11 Suppl 6():2-9. PubMed ID: 16209700
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Emerging epidemic of metallo-beta-lactamase-mediated resistances.
    Jones RN, Biedenbach DJ, Sader HS, Fritsche TR, Toleman MA, Walsh TR.
    Diagn Microbiol Infect Dis; 2005 Feb 27; 51(2):77-84. PubMed ID: 15698711
    [No Abstract] [Full Text] [Related]

  • 8. [Betalactam antibiotics combined with bectalactamases inhibitors. Amoxicillin-sulbactam].
    Barcelona L, Marín M, Stamboulian D.
    Medicina (B Aires); 2008 Feb 27; 68(1):65-74. PubMed ID: 18416324
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mechanisms of resistance to beta-lactams in some common Gram-negative bacteria causing nosocomial infections.
    Suárez CJ, Lolans K, Villegas MV, Quinn JP.
    Expert Rev Anti Infect Ther; 2005 Dec 27; 3(6):915-22. PubMed ID: 16307504
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases.
    Shah AA, Hasan F, Ahmed S, Hameed A.
    Res Microbiol; 2004 Dec 27; 155(6):409-21. PubMed ID: 15249058
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH, Chan KC, Liu HB, Chung WH, Leung YC, Wong KY.
    Anal Chem; 2005 Aug 15; 77(16):5268-76. PubMed ID: 16097768
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The current state of multidrug-resistant gram-negative bacilli in North America.
    Nicasio AM, Kuti JL, Nicolau DP.
    Pharmacotherapy; 2008 Feb 15; 28(2):235-49. PubMed ID: 18225969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.